Consultation on the EU legislation on blood, tissues and cells.
The European Commission launched a stakeholder consultation on the EU legislation on blood, tissues and cells. Further details on this consultation details are available on our Regulatory News section
- The consultation period has now ended. A response document on the outcome of the consultation will be published in due course.
Consultation on Medical Devices Distributor Guidance.
The HPRA has recently undertaken a public consultation on Medical Devices Distributor Guidance.
- The consultation period has now ended.
A consultation commenced on 29 September 2016: Annual Review and Proposal for Fees 2017
The public consultation on the annual review and proposal for fees 2017 was closed on 16th November 2016.
The HPRA would like to thank everybody who contributed to the process.
Please find below a response document providing a general overview of the comments received and the changes made to the proposals as a result.
Outcome of the Process - Public Consultation on Proposed Fees for 2017
The Introduction of a Fee Based Funding Model to Support the Conduct of Medical Device Regulatory Activities by the Health Products Regulatory Authority (HPRA)
The HPRA is undertaking a public consultation on the Introduction of a Fee Based Funding Model to Support the Conduct of Medical Device Regulatory Activities by the Health Products Regulatory Authority (HPRA). The consultation period has now ended. A response document on the outcome of the consultation will be published and further information will be made available on the introduction of a fee model in due course
Please find the consultation document below
Public Consultation on the Introduction of a Fee Based Funding Model to Support the Conduct of Medical Device Regulatory Activities by the HPRA Outcome of the Process - Public Consultation on the introduction of a fee based funding model to support the conduct of Medical Device Regulatory Activities by the HPRA
Consultation on Guide to Biosimilars for Healthcare Professionals and Patients.
The HPRA has undertaken a public consultation on Guide to Biosimilars for Healthcare Professionals and Patients. The consultation period has now ended. Please find the response document on the outcome of the consultation linked below.
Response Document - Public Consultation on Guide to Biosimilars for Healthcare Professionals and Patients
Guide to Biosimilars for Healthcare Professionals and Patients
Consultation on HPRA Strategy
Start date of consultation: 2 February 2015
Closing date of consultation: 27 March 2015
The HPRA has undertaken a public consultation on the HPRA Strategy. The consultation period has now ended. A response document on the outcome of the consultation can be found here.
This consultation complies with government policy on public consultation, as described in the document ‘Reaching out: Guidelines on Consultation for Public Sector Bodies’. In addition, the HPRA is a member of the Health and Social Care Regulatory Forum which published Guidelines for consultation.
Public consultation process on Guide for Retail Sale of Herbal Medicinal Products
The HPRA has undertaken a public consultation on the Guide for Retail Sale of Herbal Medicinal Products. The consultation period has now ended. A response document on the outcome of the consultation will be published in due course.